跳至主要内容
临床试验/IRCT2016030226876N1
IRCT2016030226876N1已完成4 期

Comparing the effectiveness of omeprazole and ranitidine in the control of signs and symptoms of gastroesophageal reflux disease in preterm neonates unresponsive to conservativel therapy

Investigator0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 28 days(—)
性别
All

入选标准

  • Healthy preterm infants with troublesome clinical manifestations of gasteroesophageal reflux disease (including wheezing, pneumonia, chronic cough, apnea, stridor, failure to thrive, seizure, anemia, sandifer syndrome, irritability, regurgitation, vomiting, rumination); non-resposive to conservative treatment including antireflux positioning and hypo-allergen regimen.
  • Exclusion criteria :
  • Abnormality of GI tract (volvulus, atresia); Drug abuse (morphine, phenobarbital);
  • Mechanical ventilation; Underlying disease (necrotizing enterocolitis, sepsis); Central nervous system abnormalities; Pripheral nervous system abnormalities, Neuro-muscular abnormalities (Myastenia gravis,Werdnig-Hoffmann disease)

排除标准

  • 未提供

研究者

发起方
Investigator

相似试验